$us1.4 billion relenza sales From Wallstreet Journal last night.
Nomura Securities upgraded British pharmaceutical giant GlaxoSmithKline to "buy" from "neutral". Nomura said the Company will reap an extra $1.4 billion of revenue from its Relenza flu treatment. Glaxo shares added 1% in London.
What does that do to everyones outlook on BTA.
- Forums
- ASX - By Stock
- BTA
- anticipate a fall today...
anticipate a fall today..., page-3
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)